- Medicare Advantage Overbilling Allegations
Federal lawsuits and audits have accused Elevance Health (and several other large insurers) of inflating patient risk scores to increase Medicare Advantage payments.
These risk scores determine how much the government reimburses insurers — so exaggerating them can lead to billions in overpayments.
The DOJ and CMS have been investigating or litigating cases against multiple insurers, including Elevance, over this.
- Claims Handling and Denials
There have been consumer and provider complaints about claim denials and delays, particularly for mental health services or out-of-network care.
Some whistleblowers and investigative journalists have argued that the company uses algorithmic claim reviews that approve or deny thousands of cases in seconds, raising ethical questions about fairness and patient care.
- Executive Pay vs. Patient Costs
Elevance’s top executives earn tens of millions annually, even as members report rising premiums and narrower provider networks.
Critics see this as evidence that the company prioritizes profits and shareholders over patient outcomes.
- Data Privacy and Security Issues
Like most major health insurers, Elevance has had data breaches and been criticized for not adequately protecting member data — especially sensitive medical information.
- Political and Lobbying Influence
Elevance Health spends millions annually on lobbying and political contributions, which some watchdogs argue gives it outsized influence over healthcare policy — often in ways that maintain high profit margins rather than expanding care access.
- Systemic Context
It’s worth noting: most of these criticisms apply across the U.S. health insurance industry, not only to Elevance. The structure of private health insurance — profit-based, tied to employer and government contracts — creates built-in incentives that can encourage minimizing payouts and maximizing revenue.